Trade

with

CollabRx Inc
(NASDAQ: CLRX)
AdChoices
0.7999
+0.0598
+8.08%
After Hours :
-
-
-

Open

0.7400

Previous Close

0.7401

Volume (Avg)

12.02k (20.64k)

Day's Range

0.6790-0.8199

52Wk Range

0.6620-6.75

Market Cap.

2.17M

Dividend Rate ( Yield )

-

Beta

1.39

Shares Outstanding

2.93M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Health Information Services
Highlights
Analyst Recommendation: Outperform
    • Revenue

    • 658.00k

    • Net Income

    • -3.31M

    • Market Cap.

    • 2.17M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -832.96

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 1.39

    • Forward P/E

    • -0.39

    • Price/Sales

    • 3.25

    • Price/Book Value

    • 0.69

    • Price/Cash flow

    • -0.58

      • EBITDA

      • -3.34M

      • Return on Capital %

      • -67.13

      • Return on Equity %

      • -90.85

      • Return on Assets %

      • -67.13

      • Book Value/Share

      • 1.08

      • Shares Outstanding

      • 2.93M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Outperform
        • 1 Year Price Target

        • 7.00

        • Credit Rating

        • -

        • Analysts

        • 1

        • EPS Estimate

        • -1.85

        • Cashflow Estimate

        • 1.64

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • -76.30

          • 20.09

          • Net Income

            YTD/YTD (last year)

          • -

          • 6.42

          • Net Income

            Q/Q (last year)

          • -

          • 15.02

          • Sales (Revenue)

            5-Year Annual Average

          • -45.00

          • 6.30

          • Net Income

            5-Year Annual Average

          • -

          • 13.11

          • Dividends

            5-Year Annual Average

          • -

          • 16.82

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 65.04

            • 80.08

            • Pre-Tax Margin

            • -909.73

            • 18.80

            • Net Profit Margin

            • -832.96

            • 8.24

            • Average Gross Margin

              5-Year Annual Average

            • 67.00

            • 78.65

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -3,385.30

            • 18.93

            • Average Net Profit Margin

              5-Year Annual Average

            • -4,525.20

            • 17.86B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.16

              • 0.09

              • Current Ratio

              • 4.46

              • 2.77

              • Quick Ratio

              • 4.07

              • 2.37

              • Interest Coverage

              • -

              • 2.09

              • Leverage Ratio

              • 1.52

              • 1.46

              • Book Value/Share

              • 1.08

              • 3.23

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -0.39

                • -13.76

                • P/E Ratio 5-Year High

                • -4.30

                • 386.45

                • P/E Ratio 5-Year Low

                • -0.33

                • 81.57

                • Price/Sales Ratio

                • 3.47

                • 4.66

                • Price/Book Value

                • 0.73

                • 10.98

                • Price/Cash Flow Ratio

                • -0.58

                • 20.58

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -90.85

                        (-53.50)

                      • 8.82

                        (13.67)

                      • Return on Assets %

                        (5-Year Average)

                      • -67.13

                        (-43.80)

                      • 6.24

                        (9.82)

                      • Return on Capital %

                        (5-Year Average)

                      • -80.93

                        (-51.10)

                      • 7.94

                        (12.13)

                      • Income/Employee

                      • -

                      • 18.36k

                      • Inventory Turnover

                      • -

                      • 18.22

                      • Asset Turnover

                      • 0.08

                      • 0.76

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      -3.59M
                      Operating Margin
                      -545.29
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      -0.58
                      Ownership

                      Institutional Ownership

                      2.03%

                      Top 10 Institutions

                      2.03%

                      Mutual Fund Ownership

                      0.18%

                      Float

                      89.25%

                      5% / Insider Ownership

                      -

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Master Extended Market Index Series

                      •  

                        1,314

                      • 0.00

                      • 0.04

                      • USAA Extended Market Index Fund

                      •  

                        1,313

                      • -0.08

                      • 0.04

                      • Marketocracy Masters 100 Fund

                      •  

                        800

                      • 0.00

                      • 0.03

                      • The Vanguard - Total Stk Mkt Idx Trust. CF

                      •  

                        751

                      • 0.00

                      • 0.03

                      • EB DL Non-SL Market Completion Fund

                      •  

                        396

                      • 482.35

                      • 0.01

                      • Vanguard US Equity Index

                      •  

                        300

                      • 0.00

                      • 0.01

                      • Fidelity Spartan® Extended Mkt Indx Fd

                      •  

                        177

                      • 0.00

                      • 0.01

                      • Mellon Cap Market Completion Strategy

                      •  

                        112

                      • 10.89

                      • 0.00

                      • Fidelity Spartan® Total Market Idx Fund

                      •  

                        87

                      • 0.00

                      • 0.00

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • BlackRock Fund Advisors

                      •  

                        34,228

                      • 0.00%

                      • 1.17

                      • First Republic Inv Mgmt, Inc.

                      •  

                        19,947

                      • 0.00%

                      • 0.68

                      • BlackRock Advisors LLC

                      •  

                        1,314

                      • 0.00%

                      • 0.04

                      • Tower Research Capital LLC

                      •  

                        819

                      • +32.31%

                      • 0.03

                      • Marketocracy Capital Management LLC

                      •  

                        800

                      • 0.00%

                      • 0.03

                      • Vanguard Quantitative Funds

                      •  

                        751

                      • 0.00%

                      • 0.03

                      • Mellon Capital Management Corporation

                      •  

                        508

                      • +200.59%

                      • 0.02

                      • Manufacturers Life Insurance Co

                      •  

                        407

                      • 0.00%

                      • 0.01

                      • Vanguard Group Inc.

                      •  

                        300

                      • 0.00%

                      • 0.01

                      • Fidelity Management & Research Company

                      •  

                        264

                      • 0.00%

                      • 0.01

                      Company Profile

                      Sector

                      Technology

                      Industry

                      Health Information Services

                      Type

                      Speculative Growth

                      Style

                      Small Core

                      CollabRx Inc formerly Tegal Corporation was formed in December 1989. The Company uses information technology to inform personalized cancer treatment planning by combining the knowledge on cutting-edge therapies with specific insights...more. This approach to molecular medicine provides physicians, patients and researchers with the ability to rapidly and accurately identify relevant drugs, clinical trials, diagnostics, medical tests and therapies associated with specific genetic profiles. The Company currently delivers its proprietary content to users via web-based applications and services in the cloud serving physicians and its patients. The Company's product Therapy Finder™ web-based application serves as an initial user-interface to the underlying knowledge base. Its clinical products are point-of-care ...moreelectronic resources to assist oncologists, other physicians and health care professionals, and cancer patients in creating a personalized treatment plan by leveraging the unique genetic profiles of a given patient’s tumor. The Company is developing Web-based resources and apps to provide expert-vetted interpretation of molecular cancer panels. The Company provides decision support tools to help physicians determine, which medical tests, therapies, and clinical trials should be considered in order to deliver care to their patients; and a framework to categorize the molecular subtypes of cancer based on the genetic profile of the tumor to researchers.lessless

                      Key People

                      Mr. Thomas R. Mika

                      CEO/CFO/Chairman of the Board/Chief Accounting Officer/Director/President/Secretary/Treasurer

                      Mr. Gavin J. Gordon

                      Vice President, Divisional

                      Clifford Joseph Baron

                      Vice President/COO

                      Mr. Jeffrey M. Krauss

                      Director

                      Mr. Carl Muscari

                      Director

                      • CollabRx Inc

                      • 44 Montgomery Street

                      • San Francisco, CA 94104

                      • USA.Map

                      • Phone: +1 415 248-5350

                      • Fax: +1 415 248-5351

                      • collabrx.com

                      Incorporated

                      1989

                      Employees

                      17

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: